Epstein-Barr virus-encoded latent membrane protein 1 activates β-catenin signaling in B lymphocytes

Cancer Science

Volumn 100, Issue 5, 2009, Pages 807-812

  Tomita, Mariko ^a   Dewan, Md Zahidunnabi ^b,c,e   Yamamoto, Naoki ^b,c   Kikuchi, Akira ^d   Mori, Naoki ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^d HIROSHIMA UNIVERSITY   (Japan)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BETA CATENIN; LATENT MEMBRANE PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PLASMID VECTOR; PROTEIN KINASE B; SMALL INTERFERING RNA;

ARTICLE; B LYMPHOCYTE; CARBOXY TERMINAL SEQUENCE; CELL IMMORTALIZATION; CONTROLLED STUDY; DELETION MUTANT; ENZYME PHOSPHORYLATION; EPSTEIN BARR VIRUS; FEMALE; GENETIC TRANSFECTION; GROWTH INHIBITION; HELA CELL; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE TRANSFORMATION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; VIRUS CELL INTERACTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; B-LYMPHOCYTES; BETA CATENIN; CELL LINE; CELL PROLIFERATION; HERPESVIRUS 4, HUMAN; HUMANS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TCF TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; VIRAL MATRIX PROTEINS;

EID: 65349095556     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01121.x     Document Type: Article

References (33)

1. Rickinson AB, Kieff E. Epstein-Barr virus and its replication. Fields Virology, 4th edn. Philadelphia, PA: Lippincott Williams & Wilkins, 2006: 2655-700.
2. Kaye KM, Izumi KM, Kieff E. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci USA 1993; 90: 9150-4.
3. Liebowitz D, Wang D, Kieff E. Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus. J Virol 1986; 58: 233-7.
4. Hammarskjold ML, Simurda MC. Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-κB activity. J Virol 1992; 66: 6496-501.
5. Paine E, Scheinman RI, Baldwin AS Jr, Raab-Traub N. Expression of LMP1 in epithelial cells leads to the activation of a select subset of NF-κB/Rel family proteins. J Virol 1995; 69: 4572-6.
6. Izumi KM, Kieff ED. The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-κB. Proc Natl Acad Sci USA 1997; 94: 12592-7.
7. Kieser A, Kilger E, Gires O, Ueffing M, Kolch W, Hammerschmidt W. Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade. EMBO J 1997; 16: 6478-85.
8. Eliopoulos AG, Blake SM, Floettmann JE, Rowe M, Young LS. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2. J Virol 1999; 73: 1023-35.
9. Eliopoulos AG, Gallagher NJ, Blake SM, Dawson CW, Young LS. Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production. J Biol Chem 1999; 274: 16085-96.
10. Roberts ML, Cooper NR. Activation of a ras-MAPK-dependent pathway by Epstein-Barr virus latent membrane protein 1 is essential for cellular transformation. Virology 1998; 240: 93-9.
11. Gires O, Kohlhuber F, Kilger E et al. Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins. EMBO J 1999; 18: 3064-73.
12. Luo J, Manning BD, Cantley LC. Targeting the PI3K-Akt pathway in human cancer: Rationale and promise. Cancer Cell 2003; 4: 257-62.
13. Dawson CW, Tramountanis G, Eliopoulos AG, Young LS. Epstein-Barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt pathway to promote cell survival and induce actin filament remodeling. J Biol Chem 2003; 278: 3694-704.
14. Mainou BA, Everly DN Jr, Raab-Traub N. Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K. Oncogene 2005; 24: 6917-24.
15. Polakis P. Wnt signaling and cancer. Genes Dev 2000; 14: 1837-51.
16. Korinek V, Barker N, Morin PJ et al. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/- colon carcinoma. Science 1997; 275: 1784-7.
17. Morin PJ. β-catenin signaling and cancer. Bioessays 1999; 21: 1021-30.
18. Tomita M, Kikuchi A, Akiyama T, Tanaka Y, Mori N. Human T-cell leukemia virus type 1 tax dysregulates β-catenin signaling. J Virol 2006; 80: 10497-505.
19. Miller G, Lipman M. Comparison of the yield of infectious virus from clones of human and simian lymphoblastoid lines transformed by Epstein-Barr virus. J Exp Med 1973; 138: 1398-412.
20. Tomita M, Choe J, Tsukazaki T, Mori N. The Kaposi's sarcoma-associated herpesvirus K-bZIP protein represses transforming growth factor β signaling through interaction with CREB-binding protein. Oncogene 2004; 23: 8272-81.
21. Ishiyama M, Tominaga H, Shiga M, Sasamoto K, Ohkura Y, Ueno K. A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol Pharm Bull 1996; 19: 1518-20.
22. Kishida M, Hino S, Michiue T et al. Synergistic activation of the Wnt signaling pathway by Dvl and casein kinase Iε. J Biol Chem 2001; 276: 33147-55.
23. Kishida S, Yamamoto H, Ikeda S et al. Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of β-catenin. J Biol Chem 1998; 273: 10823-6.
24. Shih IMYuJ, He TC, Vogelstein B, Kinzler KW. The β-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression. Cancer Res 2000; 60: 1671-6.
25. Huen DS, Henderson SA, Croom-Carter D, Rowe M. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-κB and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene 1995; 10: 549-60.
26. Floettmann JE, Rowe M. Epstein-Barr virus latent membrane protein-1 (LMP1) C-terminus activation region 2 (CTAR2) maps to the far C-terminus and requires oligomerisation for NF-κB activation. Oncogene 1997; 15: 1851-8.
27. Sharma M, Chuang WW, Sun Z. Phosphatidylinositol 3-kinase/Akt stimulates androgen pathway through GSK3β inhibition and nuclear β-catenin accumulation. J Biol Chem 2002; 277: 30935-41.
28. Dawson CW, Laverick L, Morris MA, Tramoutanis G, Young LS. Epstein-Barr virus-encoded LMP1 regulates epithelial cell motility and invasion via the ERK-MAPK pathway. J Virol 2008; 82: 3654-64.
29. Arron JR, Vologodskaia M, Wong BR et al. A positive regulatory role for Cbl family proteins in tumor necrosis factor-related activation-induced cytokine (trance) and CD40L-mediated Akt activation. J Biol Chem 2001; 276: 30011-17.
30. Suzuki H, Terauchi Y, Fujiwara M et al. Xid-like immunodeficiency in mice with disruption of the p85α subunit of phosphoinositide 3-kinase. Science 1999; 283: 390-2.
31. Fujimuro M, Wu FY, ApRhys C et al. A novel viral mechanism for dysregulation of β-catenin in Kaposi's sarcoma-associated herpesvirus latency. Nat Med 2003; 9: 300-6.
32. Shackelford J, Maier C, Pagano JS. Epstein-Barr virus activates β-catenin in type III latently infected B lymphocyte lines: association with deubiquitinating enzymes. Proc Natl Acad Sci USA 2003; 100: 15572-6.
33. Morrison JA, Klingelhutz AJ, Raab-Traub N. Epstein-Barr virus latent membrane protein 2A activates β-catenin signaling in epithelial cells. J Virol 2003; 77: 12276-84.